Pricing Log in Create free account

Biohaven Ltd. (BHVN) vs NewAmsterdam Pharma Company N.V. (NAMS)

Biohaven Ltd. and NewAmsterdam Pharma Company N.V. are both Biotechnology companies. Biohaven Ltd. and NewAmsterdam Pharma Company N.V. are of similar size ($2.3B and $2.3B). Biohaven Ltd. grew revenue faster over the last twelve months: 425.2% against −26.4%. Biohaven Ltd. has the higher net margin (0.00% vs −789.9%) and the higher return on invested capital (−6,659.9% vs −13,975.8%). Across the 16 metrics below, Biohaven Ltd. leads on 10 and NewAmsterdam Pharma Company N.V. on 6.

Valuation

Metric BHVN NAMS Biotechnology median
P/E n/m n/m 11.58
P/S 2.30 98.69 9.61
P/B n/m 4.06 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 2.40 74.41 9.43
Earnings yield (25.43%) (8.20%) (32.28%)
Free cash flow yield (21.52%) (5.89%) (22.27%)

Profitability

Metric BHVN NAMS Biotechnology median
Gross margin 0.00% 100.00% 68.81%
Operating margin 0.00% (900.07%) 0.00%
Net margin 0.00% (789.94%) 0.00%
Free cash flow margin 0.00% (581.64%) 0.00%
Return on equity 940.46% (30.16%) (50.30%)
Return on assets (161.32%) (27.79%) (45.47%)
Return on invested capital (6,659.91%) (13,975.75%) 0.00%

Growth

Metric BHVN NAMS Biotechnology median
Revenue growth (TTM) 425.20% (26.41%) 6.78%
EPS growth (last fiscal year) 26.08% 32.81% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BHVN NAMS Biotechnology median
Debt to equity (2.69) 0.00 0.00
Current ratio 3.05 11.76 4.74
Net debt to EBITDA 0.11 2.83 1.01

Dividend

Metric BHVN NAMS Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric BHVN NAMS Biotechnology median
Market cap 2.28b 2.30b 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack